companydata.dkcompanydata.dk

CHR. OLESEN PHARMACEUTICALS A/S: Financial statements 2018

CVR: 32090168

Source: annual report 2018, Danish Business Authority

01/10/2017 – 30/09/2018

CHR. OLESEN PHARMACEUTICALS A/S (CVR 32090168) has filed annual accounts for 2018. In 2018, the company reported a gross profit of EUR 467,859 and a net result of EUR 95,831 compared with EUR 127,982 the year before. That is a decrease of 11.5% compared with the year before. Equity in the 2018 report amounted to EUR -30,502. The company had 1 employee in the financial year.

Gross Profit
EUR 467,859
Profit/Loss
EUR 95,831
Equity
EUR -30,502
Total Assets
EUR 6,867,789
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-468K EUR96K EUR-31K EUR1
2017-529K EUR128K EUR-126K EUR1
2016-395K EUR21K EUR-254K EUR1
2015-326K EUR-130K EUR-295K EUR1
2014-125K EUR3.1M EUR-212K EUR1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

CHR. OLESEN PHARMACEUTICALS A/S: The 2017 annual report is outMar 1, 2018

CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2017. Gross profit came to DKK 528,524, and the net result was DKK 127,982.

About CHR. OLESEN PHARMACEUTICALS A/S

CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.

Source: annual report 2025, Danish Business Authority